FDA gives approval for new MS drug - Health - msnbc.com

Links shared publicly online about this topic.

  • 855
    total visits

FDA gives approval for new MS drug - Health - msnbc.com

msnbc.msn.com

U.S. government health regulators have approved the first pill to treat the underlying causes of multiple sclerosis, a debilitating nervous system disorder that has traditionally been treated with injectable drugs.

View full resource at msnbc.msn.com

Tags: Nervous System, Multiple Sclerosis, Multiple Sclerosis Medication, Disease and Condition, Drug, FDA

  • Share

Most Recently Shared on September 22, 2010 at 4:07 pm By:

Report: FDA strengthens monitoring of post-approval drug safety

fda.gov — “A strengthened and modernized postmarket drug safety program has resulted in a substantial improvement in the U.S. Food and Drug Administration’s oversight of drugs once they reach the American public, according to a new report released today by the agency’s Center for Drug Evaluation and Research (CDER). The report, “Advances in FDA’s Safety Program for Marketed Drugs,” describes new scientific tools and enhanced capabilities that give the same priority to postmarket drug safety monitoring as tView full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on April 21, 2012 at 8:42 pm By:

HealthTrendster HealthTrendster Health Executive

Report: FDA strengthens monitoring of post-approval drug safety: A strengthened and… http://t.co/Nlax6RLR

5 days ago...

FDA Approves Drug For Common Skin Cancer

medicalnewstoday.com — “On Monday, the US Food and Drug Administration approved a new type of drug to treat adult patients with advanced basal-cell carcinoma, the most common type of skin cancer. The drug's geView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on January 31, 2012 at 10:05 am By:

New Lymphoma Drug Gives Patients Hope : Healthymagination

healthymagination.com — “In August, the Food and Drug Administration (FDA) approved Adcetris (brentuximab vedotin), the first new drug approved to treat Hodgkin lymphoma (HL) in the last 30 years.View full resource at healthymagination.com

  • View Related
  • Share

Most Recently Shared on January 23, 2012 at 5:01 pm By:

HerpesLine Herpes on Healthline Health Site

A new drug gives Hodgkin Lymphoma patients renewed hope: http://t.co/iAI2F0a5

3 months ago...

Regeneron eye drug gets FDA nod | Reuters

reuters.com — “(Reuters) - Regeneron Pharmaceuticals said U.S. regulators approved its new drug for treating a common cause of blindness in the elderly, giving a boost to the small biotech company.The Food and DrugView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on November 19, 2011 at 12:05 am By:

FDA panel gives nod to Bayer/J&J anti-clot drug | Reuters

reuters.com — “COLLEGE PARK, Maryland (Reuters) - A new stroke preventer from Bayer and Johnson & Johnson moved one step closer to U.S. approval, but questions remained about restrictions on labeling and the needView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on September 8, 2011 at 9:03 pm By:

Reuters_Health Reuters Health Health News

FDA panel gives nod to Bayer/J&J anti-clot drug http://t.co/2oHqsmv

8 months ago...

FDA panel gives nod to Bayer/J&J anti-clot drug | Reuters

reuters.com — “COLLEGE PARK, Maryland (Reuters) - A new stroke preventer from Bayer and Johnson & Johnson moved one step closer to U.S. approval, but questions remained about restrictions on labeling and the needView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on September 8, 2011 at 8:50 pm By:

MedicalNews Medical News Health News

FDA panel gives nod to Bayer/J&J anti-clot drug http://t.co/AAa9utG

8 months ago...

FDA gives OK to new skin cancer drug; Zelboraf approved to treat late-stage melanoma

nydailynews.com — “Zelboraf got the okay to treat the most dangerous type of skin cancer, after it was shown to extend patients' survival.View full resource at nydailynews.com

  • View Related
  • Share

Most Recently Shared on August 17, 2011 at 10:29 pm By:

medwisdom OrganizedWisdom OW Health

FDA gives OK to new late-stage melanoma drug: Zelboraf got the okay to treat the most dangerous type of skin ca... http://t.co/JYk0cUC

8 months ago...

FDA Approves New Once-Daily HIV Drug - FoxNews.com

foxnews.com — “Regulators approved a once-daily HIV pill by Gilead Sciences Inc, giving a new source of revenue to the leading maker of HIV medicines as it faces expiring patentsView full resource at foxnews.com

  • View Related
  • Share

Most Recently Shared on August 11, 2011 at 3:58 pm By:

HIV_Wisdom OrganizedWisdom HIV OW Health

FDA Approves New Once-Daily HIV Drug: Regulators approved a once-daily HIV pill by Gilead Sciences Inc, giving a... http://fxn.ws/pf7Ynk

8 months ago...

FDA approves Gilead's once-daily HIV pill - Yahoo! News

news.yahoo.com — “Read 'FDA approves Gilead's once-daily HIV pill' on Yahoo! News. WASHINGTON (Reuters) - Regulators approved a once-daily HIV pill by Gilead Sciences Inc, giving a new source of revenue to the leading maker of HIV medicines as it faces expiring patents.View full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on August 11, 2011 at 3:54 am By:

HIV_Wisdom OrganizedWisdom HIV OW Health

FDA approves Gilead's once-daily HIV pill: WASHINGTON (Reuters) - Regulators approved a once-daily HIV pill by ... http://yhoo.it/mPzYkT

8 months ago...

FDA approves Gilead's once-daily HIV pill | Reuters

reuters.com — “WASHINGTON (Reuters) - Regulators approved a once-daily HIV pill by Gilead Sciences Inc, giving a new source of revenue to the leading maker of HIV medicines as it faces expiring patents.The Food andView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on August 11, 2011 at 12:34 am By:

HealthPassion HealthPassion Health News

FDA approves Gilead's once-daily HIV pill: WASHINGTON (Reuters) - Regulators approved a once-daily HIV pill by G... http://bit.ly/ngakTO

8 months ago...

FDA approves Gilead's once-daily HIV pill

health.yahoo.net — “Regulators approved a once-daily HIV pill by Gilead Sciences Inc, giving a new source of revenue to the leading maker of HIV medicines as it faces expiring patents.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on August 10, 2011 at 9:40 pm By:

FDA approves Gilead's once-daily HIV pill | Reuters

reuters.com — “WASHINGTON (Reuters) - Regulators approved a once-daily HIV pill by Gilead Sciences Inc, giving a new source of revenue to the leading maker of HIV medicines as it faces expiring patents.The Food andView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on August 10, 2011 at 9:05 pm By:

FDA approves Gilead's once-daily HIV pill | Reuters

reuters.com — “WASHINGTON (Reuters) - Regulators approved a once-daily HIV pill by Gilead Sciences Inc, giving a new source of revenue to the leading maker of HIV medicines as it faces expiring patents.The Food andView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on August 10, 2011 at 9:00 pm By:

PharmaLive: FDA approves supplemental new drug application for Novartis therapy Gilenya to include data showing reduction in T1 lesions in MS, a marker of disease activity

pharmalive.com — “PharmaLive: FDA approves supplemental new drug application for Novartis therapy Gilenya to include data showing reduction in T1 lesions in MS, a marker of disease activityView full resource at pharmalive.com

  • View Related
  • Share

Most Recently Shared on August 3, 2011 at 12:04 am By:

FiercePharma FiercePharma Health Site

Novartis MS drug Gilenya gets new label info: Data on reduced T1 lesions, a marker for disease activity. http://bit.ly/q43Gfm

9 months ago...

Think Inside the Box - NYTimes.com

nytimes.com — “We list vital facts on food packages. Why not do the same for drugs?View full resource at nytimes.com

  • View Related
  • Share

Most Recently Shared on July 5, 2011 at 11:11 am By:

DrRichardBesser Richard Besser Doctor, Pediatrician, Health Communicator, and Physician

Great idea for new prescription drug labels: NYTimes: Think Inside the Box http://nyti.ms/kjjZTa

10 months ago...

Advertisement